Stuff/NZPA: Therapy offers new hope for cancer sufferers
A rabbit virus could hold hope for people suffering with colorectal cancer, say researchers from the University of Otago. The new vaccine therapy uses a modified form of rabbit calicivirus disease...
View ArticleVitamin C found to have effect on tumours
Vitamin C, otherwise called ascorbate, has been found to have a link with cancerous tumour growth, according to University of Otago researchers. A protein present in tumours, which allows them to...
View ArticleThe Press: Future here now for women with gynaecological cancers
Rebecca Todd writes in The Press about a surgeon in Christchurch who, for the first time, is using a robot to remove gynaecological tumours. The robots allow for surgery to be more precise and ‘easy’,...
View ArticleNZ Herald: Foreign teams to work on promising NZ cancer drug
Martin Johnston writes in the New Zealand Herald about a ‘stealth’ anti-cancer drug, developed by Auckland University researchers, which is to begin clinical development overseas. The drug, PR509,...
View ArticleStuff/NZPA: Therapy offers new hope for cancer sufferers
A rabbit virus could hold hope for people suffering with colorectal cancer, say researchers from the University of Otago. The new vaccine therapy uses a modified form of rabbit calicivirus disease...
View ArticleVitamin C found to have effect on tumours
Vitamin C, otherwise called ascorbate, has been found to have a link with cancerous tumour growth, according to University of Otago researchers. A protein present in tumours, which allows them to...
View ArticleThe Press: Future here now for women with gynaecological cancers
Rebecca Todd writes in The Press about a surgeon in Christchurch who, for the first time, is using a robot to remove gynaecological tumours. The robots allow for surgery to be more precise and ‘easy’,...
View ArticleNZ Herald: Foreign teams to work on promising NZ cancer drug
Martin Johnston writes in the New Zealand Herald about a ‘stealth’ anti-cancer drug, developed by Auckland University researchers, which is to begin clinical development overseas. The drug, PR509,...
View Article
